Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SOX vs mFOLFOX6 in Resectable Rectal Cancer
NCT02280070Phase 2Unknown
- Sponsor
- Clinical Research Support Center Kyushu
- Start
- Sep 2013
- Primary completion
- Aug 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of tegafur in rectal cancer, sponsored by Clinical Research Support Center Kyushu. Status: unknown.
02
Drugs
tegafur
03
Conditions
rectal cancer
Beyond the preview
Go deeper on NCT02280070.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02280070.